Page last updated: 2024-09-05

sk&f 99085 and Malignant Melanoma

sk&f 99085 has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Floret, S; Gonzalez, R; Legha, SS; Lewis, KD; Lutzky, J; O'Day, S; Robinson, WA; Ruvuna, F; Thompson, JA; Weber, JS	1
Dorr, RT; Meyers, RO; Pourpak, A; Powell, MB; Stratton, SP	1

Trials

1 trial(s) available for sk&f 99085 and Malignant Melanoma

Article	Year
A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Investigational new drugs, 2006, Volume: 24, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Diphosphonates; Female; Humans; Male; Melanoma; Middle Aged	2006

Other Studies

1 other study(ies) available for sk&f 99085 and Malignant Melanoma

Article	Year
Cytotoxic activity of Apomine is due to a novel membrane-mediated cytolytic mechanism independent of apoptosis in the A375 human melanoma cell line. Investigational new drugs, 2007, Volume: 25, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Cell Survival; Cytosol; Diphosphonates; DNA, Neoplasm; Enzyme Activation; Genes, ras; Humans; Immunoblotting; L-Lactate Dehydrogenase; Melanoma; Poly(ADP-ribose) Polymerases; ras Proteins; Thymidine	2007

Article

Year

Cytotoxic activity of Apomine is due to a novel membrane-mediated cytolytic mechanism independent of apoptosis in the A375 human melanoma cell line.

Investigational new drugs, 2007, Volume: 25, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Cell Survival; Cytosol; Diphosphonates; DNA, Neoplasm; Enzyme Activation; Genes, ras; Humans; Immunoblotting; L-Lactate Dehydrogenase; Melanoma; Poly(ADP-ribose) Polymerases; ras Proteins; Thymidine

2007